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Abstract:  Scutellarein,  the  main  metabolite  of  scutellarin  in  vivo,  has  relatively  better 
solubility, bioavailability and bio-activity than scutellarin. However, it is very difficult to 
obtain  scutellarein  in  nature  compared  with  scutellarin.  Therefore,  the  present  study 
focused on establishing an efficient route for the synthesis of scutellarein by hydrolyzing 
scutellarin. The in vitro antioxidant activities of scutellarein were evaluated by measuring 
its scavenging capacities toward DPPH, ABTS
+•, 
•OH free radicals and its protective effect 
on H2O2-induced cytotoxicity in PC12 cells using MTT assay method. The results showed 
that essential point to the synthesis was the implementation of H2SO4 in 90% ethanol in N2 
atmosphere; scutellarein had stronger antioxidant activity than scutellarin. The results have 
laid the foundation for further research and the development of scutellarein as a promising 
candidate for ischemic cerebrovascular disease. 
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1. Introduction 
Cerebrovascular disease is a common and frequently-occurring disease that seriously endangers 
human health. It is one of the leading causes of death and disability worldwide, especially ischemic 
cerebrovascular disease, which is the most frequently prevalent [1]. Increasing evidence suggests a 
critical role of oxidative stress in ischemic cerebrovascular disease [2,3], and natural flavonoid antioxidants 
are well known as free radical scavengers [4]. Scutellarin (4′,5,6-trihydroxyﬂavone-7-glucuronide), the 
major anti-oxidant constituent in breviscapine extracted from Chinese herb of Erigeron breviscapus 
(vant.) Hand.–Mazz., showed the effectiveness on dilating blood vessels, improving microcirculation, 
increasing cerebral blood flow, and inhibiting platelet aggregation since the 1970s [5–7]. In addition, it 
has been clinically used to treat acute cerebral infarction and paralysis induced by cerebrovascular 
diseases such as hypertension, cerebral thrombosis, cerebral haemorrhage in China since 1984 [8]. 
Although scutellarin has been clinically used for a long time, scutellarin has low water-solubility 
(just  0.16  mg/mL  [9])  and  lipid-solubility  (log  P  =  −2.56  in  PBS  at  pH  4.2  [10]).  Moreover,  the 
bioavailability of scutellarin was very low; the absolute bioavailability in Beagle dog administered 
orally was rarely 0.4% [11]. Furthermore, intravenous elimination half-life in dogs was as short as   
52 min [12]. Thus, various new formulations of scutellarin have been studied to overcome the above 
disadvantages,  but  its  poor  solubility,  poor  absorption  and  low  bioavailability  have  not  been 
completely  solved  until  now.  Interestingly,  some  researchers  found  that  scutellarin  was  mainly 
absorbed in the form of its hydrolyzed product scutellarein by intestinal [13], and scutellarein was 
much more easily absorbed with the triple bioavailability, after oral administration of scutellarin and 
scutellarein  in  equal  amounts  [14].  Furthermore,  in  the  clinical  trials  [15],  a  large  amount  of 
scutellarein  was  found  in  urine  and  plasma  after  oral  administration  of  breviscapine  in  subjects, 
indicating that breviscapine was firstly hydrolyzed into aglycone when reaching colon and was then 
absorbed as scutellarein as the real bioactive components in the body. Pharmacodynamics confirmed 
that scutellarein had better protective effect than scutellarin in rat cerebral ischemia [16]. 
There  is  little  scutellarein  in  E.  breviscapus  compared  with  large  amount  of  scutellarin  [16].   
Frakas [17] and Cui [18] had already completed the total synthesis of scutellarein, but the route was long 
and the yield was low. As a result, scutellarein cannot be purchased in the market like scutellarin, and it 
is also very difficult to obtain it through other methods. Thus, we tried the synthesis of scutellarein by 
hydrolyzing scutellarin in water according to a patent [19]. Unfortunately, it was found that the reactants 
did not react. As a result, this study was intended to establish an efficient route to the synthesis of 
scutellarein  by  hydrolyzing  scutellarin,  and  to  preliminarily  investigate  its  antioxidant  activity  in 
comparison with scutellarin, which will guide the search for more potent protective agents for ischemic 
cerebrovascular disease. Int. J. Mol. Sci. 2011, 12  8210 
 
2. Materials and Methods 
2.1. Materials 
Scutellarin was purchased from Mianning Jiexiang Co. Ltd. (Chengdu, China). 1,1-Diphenyl-2- 
picrylhydrazyl (DPPH), 2,2'-azinobis[3-ethylbenzothiazoline-6-sulfonicacid]-diammonium salt (ABTS) 
were purchased from Sigma Chemical Co. (Shanghai, China). Commercial kits used for determination 
of  hydroxyl  radical  (
•OH)  scavenging  activity  was  purchased  from  Jiancheng  Institute  of 
Biotechnology (Nanjing, China). Dulbecoo’s Modified Eagles Medium (DMEM) was the product of 
Gibco.  Heat-inactivated  fetal  calf  serum  was  purchased  from  Sijiqing  Institute  of  Biotechnology 
(Hangzhou,  China).  3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium  bromide  (MTT)  was 
purchased from Fluka. PC12 cell line was obtained from Institute of Cell Biology, Chinese Academy 
of Sciences (Shanghai, China). 
2.2. General Procedure for the Synthesis of Scutellarein 
All the reagents were commercially available and used directly. Air- and moisture-sensitive liquids 
and solutions were transferred via syringe or stainless steel cannula. Organic solutions were concentrated 
by  rotary  evaporation  below  45  °C  at  approximately  20  mm  Hg.  All  non-aqueous  reactions  were 
carried out under anhydrous conditions using flame-dried glassware within an argon atmosphere in dry 
and  freshly  distilled  solvents,  unless  otherwise  noted.  Reactions  were  monitored  by  thin-layer 
chromatography (TLC) carried out on 0.15~0.20 mm Yantai silica gel plates (RSGF 254) using UV 
light as the visualizing agent. Chromatography was performed on Qingdao silica gel (160~200 mesh) 
using petroleum ether (60~90) and ethyl acetate as the eluting solvent. 
Scutellarin (0.5 g) was added to 10 mL solution of H2SO4 in 0~90% ethanol (0.5~3 mol/L). Then 
the reaction mixture was refluxed at 90~120 °C in N2 atmosphere for 6~48 h. After cooling to 25 °C, 
the reaction mixture was added to ice water; the solid was filtered and then recrystallized with 90% 
ethanol to give the target compound scutellarein. The synthesis route of scutellarein was outlined in 
Figure 1. Detailed synthesis conditions were designed in Table 1. 
Figure 1. Synthesis of scutellarein. 
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2.3. DPPH Radical-Scavenging Activity Assay 
The DPPH radical-scavenging activity assay was measured according to the method [20] with a few 
modifications. 100 µL of the sample (4~250 µmol/L, dissolved in ethanol) was added to 100 µL of 
ethanol solution containing DPPH radicals (80 µmol/L) in 96 well plates. The mixture was shaken and Int. J. Mol. Sci. 2011, 12  8211 
 
left for 30 min at room temperature in the dark, and the absorption was measured at 517 nm. Ascorbic 
acid  was  used  as  the  positive  control.  A  lower  absorbance  represents  a  higher  DPPH  scavenging 
activity. The percentage scavenging effect was calculated as scavenging rate (%) = [1 − (A1 − A2)/A0] × 
100%, where A0 was the absorbance of the control (without sample), A1 was the absorbance in the 
presence of the sample and A2 was the absorbance without DPPH. 
Table  1.  Optimization  of  reaction  conditions  in  the  synthesis  of  scutellarein  by   
hydrolyzing scutellarin. 
Run  Reaction conditions  Yield (%) 
1  1.0 mol/L H2SO4 in water, 90 °C, 6~24 h  No product 
2  2.0 mol/L H2SO4 in water, 90 °C, 6~24 h  No product 
3  3.0 mol/L H2SO4 in water, 90 °C, 6~24 h  No product 
4  0.5 mol/L H2SO4 in 70% ethanol, 90 °C, 6~24 h  No product 
5  0.5 mol/L H2SO4 in 80% ethanol, 90 °C, 6~24 h  No product 
6  0.5 mol/L H2SO4 in 90% ethanol, 90 °C, 24 h  2.1 
7  1.0 mol/L H2SO4 in 90% ethanol, 90 °C, 24 h  5.3 
8  2.0 mol/L H2SO4 in 90% ethanol, 90 °C, 24 h  8.5 
9  3.0 mol/L H2SO4 in 90% ethanol, 90 °C, 24 h  10.0 
10  3.0 mol/L H2SO4 in 90% ethanol, 90 °C, 48 h  12.1 
11  3.0 mol/L H2SO4 in 90% ethanol, 100 °C, 48 h  15.2 
12  3.0 mol/L H2SO4 in 90% ethanol, 120 °C, 48 h  17.3 
2.4. ABTS
+• Radical-Scavenging Activity Assay 
The ABTS
+• radical-scavenging activity assay was measured according to a literature procedure [21]. 
ABTS (7 mmol/L) and K2S2O8 (2 mmol/L) were dissolved and mixed in deionized water, reacting for 
12~16 h at room temperature. The mixture (ABTS
+• stock solution) was then diluted by phosphate 
buffer solution (PBS) to give an absorbance near 0.7 at 734 nm, defined as the reference absorbance 
(A0). A0 decreased to a stable value (A1) when 100 µL of ABTS
+• was mixed with 100 µL the sample   
(1~62.5  µmol/L)  for  6  min.  The  percentage  scavenging  effect  was  calculated  as  scavenging   
rate (%) = [1 − (A1 − A2)/A0] × 100%, where A0 was the absorbance of the control (without sample),   
A1 was the absorbance in the presence of the sample and A2 was the absorbance without ABTS
+•. 
2.5. 
•OH Radical-Scavenging Activity Assay 
The Hydroxyl radical-scavenging activity was measured according to the instruction of the assay kit 
(Nanjing Jiancheng Co., China). The percentage scavenging effect was calculated as scavenging rate 
(%) = [1 − (A1 − A2)/A0] × 100%, where A0 was the absorbance of the control (without sample),   
A1 was the absorbance in the presence of the sample and A2 was the absorbance without 
•OH. 
2.6. MTT Assay for PC12 Cell Survival 
Protection against oxidative stress in PC12 cells was determined using the method [22] with minor 
modifications. PC12 cells were cultured in DMEM supplemented with 10% (v/v) heat-inactivated fetal 
calf serum at 37 °C in a humidiﬁed atmosphere of 5% CO2. PC12 cells were grown on 96-well plates Int. J. Mol. Sci. 2011, 12  8212 
 
at a density of 5 × 10
4 cells/mL (100 µL/well) for 24 h. The protective effect against oxidative stress 
were tested at different concentrations in three types of experiments: (a) coincubation of PC12 cells 
with sample and H2O2; (b) preincubation of cells for 30 min with sample before exposing them to 
H2O2; (c) preincubation of cells for 8 h with sample before exposing them to H2O2. After incubation 
for 3 h with H2O2 (400 µmol/L) at 37 °C in CO2 incubator, the cells were incubated with the 0.5 mg/mL 
MTT for 4 h. Then, all culture media were removed and 150 µL of DMSO was added to each well, 
vigorously shaking for 10 min. Finally, the absorbance was assessed at 517 nm. The inhibiting rate of 
H2O2-induced cytotoxicity in PC12 cells was calculated as inhibiting rate (%) = [(A1 − A2)/(A0 − A2)] × 100%, 
where A1 was the  absorbance in the presence of sample and H2O2, A2 was the absorbance in the 
presence of H2O2 (model), A0 was the absorbance without sample and H2O2 (normal). 
3. Results and Discussion 
3.1. Optimization of Reaction Conditions for the Synthesis of Scutellarein 
The optimization of reaction conditions were shown in Table 1. The concentrated sulfuric acid was 
selected as a catalyst. Firstly, 0.5 g of scutellarin was added to 10 mL of 1 mol/L H2SO4 in water, and 
the reaction was taken at 90 °C for 6~24 h in N2 atmosphere. However, there was no product; even the 
concentration of H2SO4 increased from 1 mol/L (Table 1, run 1) to 3 mol/L (Table 1, run 3), due to the 
poor  water  solubility  of  scutellarein.  Then,  the  solvent  of  water  was  changed  into  ethanol,  where 
scutellarein had good solubility. After several attempts, we found that increasing the concentration of 
ethanol (Table 1, run 4–6) accelerated its hydrolysis and the yield increased to 2.1% in 90% ethanol 
(Table 1, run 6). Subsequently, the concentration of H2SO4 was optimized, when the concentration of 
H2SO4 increased from 1.0 mol/L (Table 1, run 7) to 3.0 mol/L (Table 1, run 9), the yield of scutellarein 
was improved from 5.3% to 10.0%, and the yield could increase to 12.1% when the reaction time 
extended to 48 h (Table 1, run 10). Lastly, the exogenous reaction temperature was studied in this 
reaction. When the reaction temperature was raised from 90 °C (Table 1, Run 10) to 120 °C (Table 1, 
Run 12), the yield of scutellarein increased from 12.1% to 17.3%. As a result, 3.0 mol/L H2SO4 in 90% 
ethanol and in N2 atmosphere at 120 °C for 48 h was implemented in the synthesis of scutellarein. 
3.2. DPPH, ABTS
+•, 
•OH Radical-Scavenging Activity 
DPPH, ABTS
+• (both stable radicals) and 
•OH (generated by Fenton reaction), are widely used to 
evaluate the antioxidant capacity of complex mixtures and individual compounds [21]. The in vitro 
antioxidant activity of scutellarein in comparison with scutellarin was evaluated by DPPH, ABTS
+•, 
•OH radical-scavenging activity assays. The IC50 value is defined as the concentration of sample that 
causes 50% loss of the radical. As illustrated in Figure 2 and Table 2, scutellarein (IC50 16.84 µmol/L 
for DPPH, 3.00 µmol/L for ABTS
+•, 0.31 mmol/L for 
•OH) had stronger radical-scavenging capacities 
than scutellarin (IC50 17.56 µmol/L for DPPH, 3.53 µmol/L for ABTS
+•, 3.19 mmol/L for 
•OH), which 
indicated that scutellarein is an effective natural antioxidant that might be a promising candidate for 
ischemic cerebrovascular disease. 
 Int. J. Mol. Sci. 2011, 12  8213 
 
Figure  2.  (A)  The  1,1-Diphenyl-2-picrylhydrazyl  (DPPH)  radical-scavenging  activity 
assay; (B) 2,2'-azinobis[3-ethylbenzothiazoline-6-sulfonicacid]- diammonium salt (ABTS
+•) 
radical-scavenging  activity  assay;  (C)  hydroxyl  radical  (
•OH)  radical-scavenging   
activity assay. 
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Table 2. In vitro antioxidant activity of scutellarein in comparison with scutellarin in DPPH 
assay (IC50 in µmol/L), ABTS
+• assay (IC50 in µmol/L), 
•OH assay (IC50 in mmol/L). 
Compounds 
IC50 
DPPH (µmol/L)  ABTS
+• (µmol/L) 
•OH (mmol/L) 
Scutellarein  16.84  3.00  0.31 
Scutellarin  17.56  3.53  3.19 
Vitamin C  24.81  12.56  1.12 
3.3. Protective Effect on H2O2-Induced Cytotoxicity in PC12 Cells 
PC12  cells  can  adopt  a  neuronal  phenotype  and  have  been  used  extensively  as  a  model  for 
catecholamine-secreting neuronal cells [23]. Active mitochondria of living cells can cleave MTT to 
produce formazan, the amount of which is directly related to the number of living cells. As shown in 
Table 3, cell viability markedly decreased after PC12 cells were exposed to H2O2. However, when the 
cells  were  incubated  with  scutellarein  or  scutellarin,  H2O2-induced  cell  toxicity  was  significantly 
attenuated, and the protective effect of scutellarein was dose-dependent. However, coincubation of 
cells showed better protective effect than preincubation for some time against H2O2 cytotoxicity, and 
the  protective  effect  decreased  as  preincubation  time  was  prolonged,  which  may  be  due  to  the 
unstability  of  scutellarein.  Therefore,  coincubation  was  considered  to  more  effectively  evaluate 
cytoprotection  of  scutellarein;  and  scutellarein  showed  a  significantly  better  protective  effect  than 
scutellarin. The cellular protective effect of scutellarein might be resulted from its antioxidant action 
mainly including preventing lipid peroxidation by eliminating radicals [24,25]. Int. J. Mol. Sci. 2011, 12  8214 
 
Table 3. Attenuation of H2O2-induced PC12 cell damage by scutellarein (x ± s, n = 5). 
Drug 
(µmol/L) 
Coincubation  Preincubation for 30 min  Preincubation for 8 h 
A517 
Inhibiting 
Rate (%) 
A517 
Inhibiting 
Rate (%) 
A517 
Inhibiting 
Rate (%) 
Normal  0.550 ± 0.004  —  0.589 ± 0.003  —  0.624 ± 0.004  — 
H2O2  0.353 ± 0.006 
##  —  0.319 ± 0.0123 
##  —  0.375 ± 0.015 
##  — 
Scutellarin/100  0.433 ± 0.009 **  40.78  0.440 ± 0.009 **  44.81  0.482 ± 0.002 **  42.97 
Scutellarein/100  0.540 ± 0.038 **  94.92  0.500 ± 0.040 **  67.04  0.458 ± 0.013 **  33.33 
Scutellarein/10  0.422 ± 0.007 **  35.32  0.395 ± 0.019 **  28.12  0.414 ± 0.002 **  15.96 
Scutellarein/1  0.362 ± 0.002  4.57  0.336 ± 0.007 *  6.10  0.383 ± 0.010  — 
** p < 0.01, * p < 0.05 vs. H2O2 group; 
## p < 0.01 vs. Normal group. 
4. Conclusion 
In  summary,  an  efficient  route  was  reported  for  the  synthesis  of  scutellarein  by  hydrolyzing 
scutellarin.  Essential  to  the  synthesis  was  the  implementation  of  H2SO4  in  90%  ethanol  in  N2 
atmosphere.  The  in  vitro  antioxidant  assays  clearly  demonstrated  that  scutellarein  had  stronger 
scavenging  capacities  toward  DPPH,  ABTS
+•, 
•OH  free  radicals  than  scutellarin,  and  had  better 
protective effect on H2O2-induced cytotoxicity in PC12 cells. The results suggested that it would be a 
promising potent agent for the therapy of ischemic cerebrovascular disease. In addition, these findings 
concluded  the  need  for  further  study  on  the  pharmacokinetics  and  its  bioactivities  other  than 
antioxidant activities. 
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